<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02609360</url>
  </required_header>
  <id_info>
    <org_study_id>1897</org_study_id>
    <nct_id>NCT02609360</nct_id>
  </id_info>
  <brief_title>Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming</brief_title>
  <official_title>Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crystalloid solutions modify acid-base equilibrium according to their electrolyte
      composition. Moreover, it has been suggested that these alterations are generated by the
      difference between the solution strong ion difference (SID) and the plasma bicarbonate level.
      An increased risk of acute kidney injury and renal replacement therapy has been associated to
      the infusion of chloride rich crystalloids. This study aims to compare, in patients with
      acute respiratory failure undergoing ECMO support, the effects on acid-base status and renal
      function of crystalloids commonly employed for circuit priming to a balanced solution created
      with a SID equal to patients' bicarbonate level.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation in Acid-Base Equilibrium (Base Excess)</measure>
    <time_frame>First 24 hours after ECMO start</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variation in Acid-Base Equilibrium (pH)</measure>
    <time_frame>First 24 hours after ECMO start</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation in Renal Function</measure>
    <time_frame>First 24 hours after ECMO start</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>0.9% NaCl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Circuit priming will be performed with 0.9% NaCl solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ringer Lactate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Circuit priming will be performed with Ringer Lactated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balanced Solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Circuit priming will be performed with a Balanced Solution created by mixing 0.9% NaCl, Sodium bicarbonate (8.4%) and injectable sterile water, in order to obtain a solution with constant sodium concentration (140 mEq/l) and SID equal to patient's bicarbonate level.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Priming of ECMO circuit with 0.9% NaCl</intervention_name>
    <description>0.9% NaCl as priming crystalloid solution</description>
    <arm_group_label>0.9% NaCl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Priming of ECMO circuit with Ringer Lactate</intervention_name>
    <description>Ringer Lactate as priming crystalloid solution</description>
    <arm_group_label>Ringer Lactate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Priming of ECMO circuit with Balanced Solution</intervention_name>
    <description>Balanced Solution as priming crystalloid solution</description>
    <arm_group_label>Balanced Solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Acute Respiratory Failure in need for ECMO treatment

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pietro Caironi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pietro Caironi, MD</last_name>
    <phone>+39-02-55033232</phone>
    <email>pietro.caironi@unimi.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pietro Caironi, MD</last_name>
      <phone>+39-02-55033232</phone>
      <email>pietro.caironi@unimi.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2015</study_first_submitted>
  <study_first_submitted_qc>November 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>November 17, 2015</last_update_submitted>
  <last_update_submitted_qc>November 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Respiratory Failure</keyword>
  <keyword>ARDS</keyword>
  <keyword>ECMO</keyword>
  <keyword>Lung transplantation</keyword>
  <keyword>Acid-Base Equilibrium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

